26 September 2022>: Articles
Alleviation of Post-COVID-19 Cognitive Deficits by Treatment with EGb 761: A Case Series
Unusual or unexpected effect of treatmentUdo A. Zifko E* , Muhammad Yacob E , Benedikt J. Braun B , Gunnar P.H. Dietz E
Am J Case Rep 2022; 23:e937094
Figure 1. The COVID-19 pandemic left many patients with long-lasting cognitive or psychiatric symptoms. Here, we report a substantial alleviation of those symptoms in 5 patients after treatment with Ginkgo extract EGb 761®. Indicated below the Ginkgo leaf is the structure of bilobalide B, a terpene lactone which is one of several hundred compounds present in EGb 761®. Drawing by Ulrike Möltgen.